Departament de Biologia Cellular Fisiologia i Immunologia, Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
BMC Cancer. 2010 Jun 11;10:280. doi: 10.1186/1471-2407-10-280.
Aneuploidy, centrosome abnormalities and gene amplification are hallmarks of chromosome instability (CIN) in cancer. Yet there are no studies of the in vivo behavior of these phenomena within the same bladder tumor.
Twenty-one paraffin-embedded bladder tumors were analyzed by conventional comparative genome hybridization and fluorescence in situ hybridization (FISH) with a cyclin D1 gene (CCND1)/centromere 11 dual-color probe. Immunofluorescent staining of alpha, beta and gamma tubulin was also performed.
Based on the CIN index, defined as the percentage of cells not displaying the modal number for chromosome 11, tumors were classified as CIN-negative and CIN-positive. Fourteen out of 21 tumors were considered CIN-positive. All T1G3 tumors were included in the CIN-positive group whereas the majority of Ta samples were classified as CIN-negative tumors. Centrosome clustering was observed in six out of 12 CIN-positive tumors analyzed. CCND1 amplification in homogeneously staining regions was present in six out of 14 CIN-positive tumors; three of them also showed amplification of this gene in double minutes.
Complex in vivo behavior of CCND1 amplicon in bladder tumor cells has been demonstrated by accurate FISH analysis on paraffin-embedded tumors. Positive correlation between high heterogeneity, centrosome abnormalities and CCND1 amplification was found in T1G3 bladder carcinomas. This is the first study to provide insights into the coexistence of CCND1 amplification in homogeneously staining regions and double minutes in primary bladder tumors. It is noteworthy that those patients whose tumors showed double minutes had a significantly shorter overall survival rate (p < 0.001).
非整倍体、中心体异常和基因扩增是癌症中染色体不稳定性(CIN)的标志。然而,目前还没有研究同一膀胱癌中这些现象的体内行为。
对 21 例石蜡包埋膀胱癌进行常规比较基因组杂交和荧光原位杂交(FISH)分析,使用细胞周期蛋白 D1 基因(CCND1)/着丝粒 11 双色探针。还进行了α、β和γ微管蛋白的免疫荧光染色。
根据 CIN 指数定义为染色体 11 非整倍体细胞的百分比,肿瘤被分为 CIN 阴性和 CIN 阳性。21 例肿瘤中有 14 例被认为是 CIN 阳性。所有 T1G3 肿瘤均归入 CIN 阳性组,而大多数 Ta 样本被归类为 CIN 阴性肿瘤。在分析的 12 例 CIN 阳性肿瘤中有 6 例观察到中心体聚集。在 14 例 CIN 阳性肿瘤中有 6 例存在均染区 CCND1 扩增;其中 3 例还显示该基因在双微体中扩增。
通过对石蜡包埋肿瘤进行准确的 FISH 分析,证明了膀胱癌细胞中 CCND1 扩增体的复杂体内行为。在 T1G3 膀胱癌中发现高异质性、中心体异常和 CCND1 扩增之间存在正相关。这是第一项研究,提供了对原发性膀胱癌中均染区 CCND1 扩增和双微体共存的深入了解。值得注意的是,那些肿瘤显示双微体的患者的总生存率显著降低(p<0.001)。